Showing results (1361-1370 of 6,769) with videos related to
Sort By:
Pageof 677
Clinical Therapeutics|March 20, 2016
Validation of a Patient-reported Outcome (PRO) Measure and a Clinician-reported Outcome (CRO) Measure to Assess Satisfaction with Pharmacologic Stress Agents for Single-photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)Stacie Hudgens, James Spalding, Paresh ChaudhariClinical Therapeutics|February 15, 2016
Identification of Patient Characteristics Influencing Setting of Care Decisions for Patients With Acute Bacterial Skin and Skin Structure Infections: Results of a Discrete Choice ExperimentSuzanne Lane, Karissa Johnston, Katherine A Sulham, et al.Clinical Therapeutics|February 15, 2016
Seasonal Patterns of Medications for Treating Attention-Deficit/Hyperactivity Disorder: Comparison of Methylphenidate and AtomoxetineYu-Chiau Shyu, Sheng-Yu Lee, Shin-Sheng Yuan, et al.Clinical Therapeutics|March 15, 2016
Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic HealthJuliette C MadanClinical Therapeutics|March 16, 2016
Gap Between Official Guidelines and Clinical Practice for the Treatment of Rheumatoid Arthritis in São Paulo, BrazilIara Alves de Camargo, Bruna Cipriano Almeida Barros, Miriam Sanches do Nascimento Silveira, et al.Clinical Therapeutics|May 1, 1989
Transferring patients with insulin-dependent diabetes mellitus from animal-source insulins to recombinant DNA human insulin: clinical experienceJ K DavidsonClinical Therapeutics|March 14, 2016
The Microbiome in Necrotizing Enterocolitis: A Case Report in Twins and MinireviewSuchitra K Hourigan, Allison Ta, Wendy S W Wong, et al.Clinical Therapeutics|December 9, 2014
Pharmacokinetic comparison study of a combination containing 500 mg of Naproxen and 20 mg of Esomeprazole: a randomized, single-dose, 2-way crossover, open-label study in healthy Korean menHyun-Gyu Choi, Ji-Young Jeon, Seong-Shin Kwak, et al.Clinical Therapeutics|December 28, 2014
Single- and multiple-dose pharmacokinetics of a hydrocodone bitartrate extended-release tablet formulated with abuse-deterrence technology in healthy, naltrexone-blocked volunteersMona Darwish, Ronghua Yang, William Tracewell, et al.Clinical Therapeutics|September 1, 1989
Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazoleC S Ingalls, P Somani, E H FreimerPageof 677